5AM Partners IV, LLC, 10% Owner at Pear Therapeutics, Inc. (PEAR), sold 94,686 shares at $2.78 ($263K) on 2022-10-31, disclosed to the SEC on 2022-11-02.
Open-market sale of $263k PEAR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.78 | 1,687 | $5K | 1.8% |
| 2 | $2.78 | 40,477 | $113K | 42.8% |
| 3 | $2.78 | 40,477 | $113K | 42.8% |
| 4 | $2.80 | 59 | $165 | 0.1% |
| 5 | $2.80 | 1,408 | $4K | 1.5% |
| 6 | $2.72 | 423 |
| $1K |
| 0.4% |
| 7 | $2.72 | 10,155 | $28K | 10.5% |
| Total | $2.77 avg | 94,686 | $263K | 100% |
| Filing → |
| APRE | SELL | 2020-05-21 | $9.0M | — | Filing → |
| SCPH | BUY | 2017-11-21 | $9.2M | — | Filing → |